saplin

UTI - MNC Fund

UTI - MNC Fund (Direct, Growth): saplin Score 5.9/10 (Weak) among 7 Sectoral/Thematic funds. 3Y return 9.4% a year vs 8.3% category median, expense ratio 1.54%. Uneven returns hold this fund back. NAV ₹447.86 on 11 Nov 2026.

Loading the full analysis…

Questions about UTI - MNC Fund

What is the expense ratio of UTI - MNC Fund?

The Direct plan's total expense ratio is 1.54% a year, against a median of 1.38% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages UTI - MNC Fund?

Karthikraj Lakshmanan (since 16 Nov 2022).

What are the top holdings of UTI - MNC Fund?

Maruti Suzuki India 7.07%, Bosch 5.25%, Hindustan Unilever 4.85%, Gland Pharma 4.52%, Nestle India 4.32% of the portfolio, as of 31 Oct 2026.

What returns has UTI - MNC Fund given?

1 year: -0.8% (category median 5.1%); 3 years: 9.4% a year (category median 8.3%); 5 years: 7.8% a year. Past returns do not predict future ones.

How big is UTI - MNC Fund?

About ₹2,745 cr (AMFI's average for the latest quarter).

How does UTI - MNC Fund score?

5.9 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on UTI - MNC